Evidence map›Paper›PMID 34356893›Full record

ArticleBiomedicines2021

Biphasic Effects of Blue Light Irradiation on Human Umbilical Vein Endothelial Cells.

Kejia Kan, Yifei Mu, Marielle Bouschbacher, Carsten Sticht, Natalia Kuch, Martin Sigl, Nuh Rahbari, Norbert Gretz, Prama Pallavi, Michael Keese

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Kejia KanDepartment of Vascular Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.ORCID 0000-0002-6340-1990
Yifei MuDepartment of Vascular Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Marielle BouschbacherUrgo Research Innovation and Development, 21300 Chenôve, France.ORCID 0000-0001-6958-1673
Carsten StichtNGS Core Facility, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Natalia KuchDepartment of Vascular Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Martin SiglFirst Department of Medicine, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Nuh RahbariDepartment of Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Norbert GretzMedical Research Centre, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Prama PallaviDepartment of Vascular Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Michael KeeseDepartment of Vascular Surgery, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
Heidelberg University · DEUrgo Laboratories (France) · FR

Funding

China Sponsorship Council 201706230250; 201706230257
6 · The paper itself

Abstract

Blue light regulates biological function in various cells, such as proliferation, oxidative stress, and cell death. We employed blue light illumination on human umbilical vein endothelial cells utilizing a LED device at 453 nm wavelength and revealed a novel biphasic response on human umbilical vein endothelial cells (HUVECs). The results showed that low fluence blue light irradiation promoted the fundamental cell activities, including cell viability, migration and angiogenesis by activating the angiogenic pathways such as the VEGF signaling pathway. In contrast, high fluence illumination caused the opposite effect on those activities by upregulating pro-apoptotic signaling cascades like ferroptosis, necroptosis and the p53 signaling pathways. Our results provide an underlying insight into photobiomodulation by blue light and may help to implement potential treatment strategies for treating angiogenesis-dependent diseases.

Indexed as

angiogenesisapoptosisblue lightendothelial cellphotobiomodulationreactive oxygen species

Identifiers

PMID34356893
PMCPMC8301484
OpenAlexW3183964490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.